Bristol-Myers Squibb Company · NYSE:BMY

Bristol-Myers Squibb — Bristol-Myers Squibb Foundation — Bristol-Myers Squibb Foundation Grantee Summit 2018

32 slides from Bristol-Myers Squibb's conference presentation, April 2018

  1. Slide 1: Bristol-Myers Squibb Foundation Grantee Summit 2018

    Bristol-Myers Squibb Foundation Grantee Summit 2018 Charleston, South Carolina | April 9-11, 2018

  2. Slide 2: LuCa National Training Network

    LuCa National Training Network Kentucky Cancer Program – University of Louisville Celeste T. Worth, MCHES Connie L. Sorrell, MPH Ruth Mattingly, MPA Morel Jones, MPH

  3. Slide 3: Project Goal and Objectives

    Project Goal and Objectives Establish a national education and training center/network to improve lung cancer care across the continuum of disease. 1. Engage health systems in the delivery of optimal lung cancer care among provider networks 2. Create partnerships with national and state professional

  4. Slide 4: Innovation

    Innovation • First national effort to educate providers, through intermediary organizations, on lung cancer • Project seeks to build capacity for improving provider awareness, knowledge, and efficacy around managing those at risk for and diagnosed with lung cancer • First national attempt to raise t

  5. Slide 5: Anticipated Challenges/Questions

    Anticipated Challenges/Questions: • Challenge of working with health systems having changing priorities (not being lung cancer) and convincing them that it’s to their benefit to educate providers on all facets of lung cancer care. • Question of when starting the national efforts, whether to be more

  6. Slide 6: Lung B.A.S.E.S. 4 Life Program

    Lung B.A.S.E.S. 4 Life Program Levine Cancer Institute -Atrium Health Co-PI’s: Mellisa Wheeler MHA, Derek Raghavan MD PhD Mellisa Wheeler, Director, Dr. Daniel Carrizosa, Medical Director Darcy Doege, Program Coordinator

  7. Slide 7: Project Goals, Objectives and Activities

    Project Goals, Objectives and Activities • The first Mobile Lung Cancer Screening Unit • DATA FROM FIRST 186 CASES • Designed to target vulnerable populations • 195 nodules detected throughout North and South Carolina • 4 biopsy-proven cancers • Programmed local education to community partners and p

  8. Slide 8: Our System at a Glance

    Our System at a Glance:” Our full continuum of care includes: 900 care locatic throughout the Carolinas © Freestanding emergency departments © Urgert care centers aft gy as 65,000+ 11.6 million erolopees patent encounters We're committed to: * Providing extensive support to advance medical research

  9. Slide 9: Innovation

    Innovation • The Lung BASES 4 Life Program is the first of its kind in the United States. • By utilizing mobile medicine to offer screening to underserved patients, it allows for barriers of poor access, geographic isolation, lack of health education and poverty to be overcome. These are established

  10. Slide 10: Key Challenges to Date

    Key Challenges to Date • Certificate of Need in North and South Carolina • Smoking Cessation • Getting people to quit • Follow through with quitting • Does screening encourage people to quit • Definitive work-up and treatment of nodules • Follow up care and no shows • Impact of negative initial scre

  11. Slide 11: A Collaborative Partnership with 20+ Institutions

    A Collaborative Partnership with 20+ Institutions Lead Organization - Maine Medical Center Paul Han, MD, MA, MPH (PI) Neil Korsen, MD, MS (Co-PI)

  12. Slide 12: MLCC Rationale, Goals & Vision

    MLCC Rationale, Goals & Vision • Maine has a high lung cancer burden: 6th highest incidence, 12th highest mortality in US 11th highest prevalence of current smokers in US Environmental risk factors (radon, arsenic) Geographic, sociodemographic inequalities— rural burden • Goals - Reduce overall & di

  13. Slide 13: Innovation: Multi-pronged Approach

    Innovation: Multi-pronged Approach Prevention & Screening; Research & Implementation; Clinic & Community; Systems & Persons; Providers & Patients • Prevention Formative research: focus groups with 50 disengaged rural adults Community health workers linking primary care patients to services Primary c

  14. Slide 14: Challenges: Rural At-Risk People Report Systemic and Personal Barriers

    Challenges: Rural At-Risk People Report Systemic and Personal Barriers to Evidence-based Care • Fatalism: Focus group participants doubt they can reduce risk “What’s the chances of me … not dying of cancer ... Kind of like it’s inevitable.” “I think … I’ll just accept dying rather than … go through

  15. Slide 15: Lung Cancer Screening

    Lung Cancer Screening Ralph Lauren Center for Cancer Care Diani Nevares Ettice Womble Lewis J. Kampel, M.D.

  16. Slide 16: Project Goals, Objectives and Activities

    Project Goals, Objectives and Activities • Ultimate goal is to develop techniques that would lead to reduction in lung cancer incidence and mortality in Harlem and surrounding communities. • Outreach to more than 10,000 people • FQHCs, health fairs, community advisory boards etc. • Patients and fami

  17. Slide 17: Key Challenges to Date

    Key Challenges to Date • Yogi Berra Principle: “If they won’t come you can’t stop em” • Lack of onsite CT created barriers to screening • Multiple appointments needed for screening to be completed • Insurance issues created barriers to screening • Navigators were unable to overcome problems with out

  18. Slide 18: ACS Health centers Advancing Lung cancer Early detection (HALE) Pilot

    The American Cancer Society’s Health centers Advancing Lung cancer Early detection (HALE) Pilot Shauna Shafer Health Systems Manager, Primary Care

  19. Slide 19: Project Goals, Objectives and Activities

    Project Goals, Objectives and Activities • The American Cancer Society (ACS) HALE pilot is working in 2 communities to: Help FQHC’s implement systems to identify patients eligible for low dose CT (LDCT) Stimulate collaboration among local partners and support development of structures and relationsh

  20. Slide 20: Innovation

    Innovation Lung cancer screening - LDCT should be thought of as a process, not a one-time test. Reduction of Barriers • Insurance payment on 3-6 month follow up • CMS guidelines on follow up (diagnostic –vs- screening) • WV Medicaid Director looking at ways to reduce barriers

  21. Slide 21: Key Challenges to Date

    Key Challenges to Date Reduction of Barriers to follow-up/repeat screenings • 23% of the 196 patients screened have been RAD 3 and RAD 4 • 3-6 month follow up being done as Chest CT not LDCT • Loss of RAD classification Closing the loop between PCP and Specialist

  22. Slide 22: Clinical Translational Science

    Clinical Translational Science

  23. Slide 23: Network

    Network

  24. Slide 24: Screening Participant Data Collection and Site Activation Process

    Collect Screening Participant Case Level Data & Enter into Study Database Site Activation Visit: Baseline: Month 6, Month 12, Month 18: Central Study Project Study Site: Sites With Active Screening Programs Study Site: Team: Implementation Collect Implementation Factors Data Site Assessment Visit Fa

  25. Slide 25: KY LEADS Study Resource Portal

    HealthCare MARKEY CANCER CENTER Network yr KENTUCKY LEADS COLLABORATIVE LUNG CANCER KY LEADS: Lung Cancer Screening ‘Study CME/CE Modules Faculty Information Pre-test For Radiologists For Lung Cancer Screening Program Team @ Kentucky LEADS: Implementation: of Quality Eing Gancer Scteening Welcome We

  26. Slide 26: Markey Cancer Center Network

    HealthCare MARKEY CANCER CENTER Network

  27. Slide 27: Lessons Learned: Database Transition and Team Adaptation

    • Transition from Internal Research Database to Commercial Product • More time than expected to modify commercial product, but result is better • Required modification for Kentucky-centric data elements • High incidence of Histoplasmosis, false-negative rate • Capture radon levels in region of karst

  28. Slide 28: VA-PALS: Veterans Affairs Partnership to Increase Access to Lung Screening

    VA-PALS: Veterans Affairs Partnership to Increase Access to Lung Screening PI: Drew Moghanaki, MD, MPH Clinical co-PI: Claudia Henschke, PhD, MD Technical co-PI: Rick Avila, MS

  29. Slide 29: Project Goals, Objectives and Activities

    Project Goals, Objectives and Activities Goals: • Implement the IELCAP screening management system at 10 VA medical centers • Facilitate future expansion by studying the implementation process and impact on care Objectives and Activities • Develop a scaleable lung screening tracking system that is b

  30. Slide 30: Innovation

    Innovation • Expanded access to IELCAP management protocol • Developing Quality Control methods within VA (LDCT phantom, dual reads) • Establishing outreach models to reach rural veterans

  31. Slide 31: Key Challenges to Date

    Key Challenges to Date • Site-readiness, approval process, hiring navigators • Radiology knowledge with lung screening, questions about Lung-RADS vs IELCAP • Leveraging MOA between Veterans Affairs and American Cancer Society • Identifying new criteria to offer screening (e.g. industrial exposures)

  32. Slide 32: Please complete the evaluation. Thank you!

    Please take a moment to complete the evaluation for today. Thank you!

Bristol-Myers Squibb Foundation — Bristol-Myers Squibb Foundation Grantee Summit 2018 on 6ix